SCHEMBL3484527

SCHEMBL3484527

BrCc1ccccc1Sc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.47
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
HPGD P15428 1/20 0.46
LMNA P02545 1/20 0.45
SLC6A4 P31645 5/20 0.44
SLC6A2 P23975 4/20 0.44
SLC6A3 Q01959 3/20 0.44
CYP2D6 P10635 2/20 0.43
GFER P55789 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
HTR1A P08908 1/20 0.41
HTR3A P46098 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NSD2 O96028 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4446684 0.86 LMNA (0.47) CHRNA7SMN1; SMN2LMNASLC6A4SLC6A2
SCHEMBL1191221 0.84 SLC6A4 (0.63) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL11011298 0.81 SLC6A2 (0.44) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL5659551 0.79 SMN1; SMN2 (0.41) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL9472324 0.78 APOBEC3G (0.61) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL5333062 0.78 CHRNA7 (0.53) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL223717 0.78 CHRNA7 (0.53) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL29582043 0.78 CHRNA7 (0.53) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL1786728 0.78 CHRNA7 (0.53) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD
SCHEMBL15850627 0.77 CHRNA7 (0.51) CHRNA7SMN1; SMN2CYP2C9CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 CHRNA7 3392/4885SMN1; SMN2 627/4885CYP2C9 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.